A.J. Rice

Stock Analyst at UBS

(2.23)
# 958
Out of 5,347 analysts
271
Total ratings
56.64%
Success rate
20.26%
Average return
47 Stocks
Name Action PT Current % Upside Ratings Updated
CCRN Cross Country Health...
Maintains: Neutral
19 17
13.16 25.38% 7 May 13, 2025
AMN AMN Healthcare Servi...
Maintains: Neutral
30 26
21.11 20.8% 10 May 13, 2025
MD Pediatrix Medical Gr...
Maintains: Neutral
19 16
14.14 13.15% 17 May 12, 2025
AVAH Aveanna Healthcare H...
Maintains: Sell
5 5
5.33 -6.19% 8 May 9, 2025
BXP BXP
Maintains: Neutral
80 68
67.37 0.94% 1 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 88
78.01 12.81% 12 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
217 230
168.75 36.3% 10 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
38 40
32.65 22.51% 2 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 15
14.08 6.53% 11 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
5 5
3.88 5.67% 6 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 30
23.79 26.1% 4 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
40 21
15.29 37.34% 7 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
79 80
56.44 41.74% 15 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
175
147.19 18.89% 1 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
605 555
383.71 44.64% 2 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
38
23.61 60.95% 1 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
9.93 403.52% 1 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
247 267
190.4 40.23% 13 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
n/a n/a 2 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
10
10.47 -9.26% 2 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
250 50
n/a n/a 3 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
450 485
719.53 -32.59% 1 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
95
22.62 319.98% 13 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
311 316
381.44 -17.16% 12 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 96
64.04 49.91% 6 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
62 73
120.92 -39.63% 8 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
635 575
232.97 146.81% 9 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
38
22.98 65.36% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
590 610
301.21 102.52% 12 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
308 305
248.82 22.58% 4 Nov 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
64 79
154.46 -48.85% 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
175 182
n/a n/a 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
350 410
305.08 34.39% 3 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18
n/a n/a 1 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 37
6.6 460.61% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
158 143
173.43 -17.55% 9 Jul 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 43
11.27 281.54% 7 Jul 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 37
n/a n/a 3 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
181 182
94.11 93.39% 5 Apr 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
181 170
n/a n/a 4 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 270
316.62 -14.72% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
382 425
n/a n/a 7 Apr 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
28.48 -98% 3 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
4
n/a n/a 1 Jan 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
207 205
n/a n/a 7 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 65
n/a n/a 5 Jul 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 44
n/a n/a 2 Jan 31, 2018